Busulfan-cyclophosphamide vs fludarabine-busulfan for allogeneic transplant in acute myeloid leukemia
Myeloablative FluBu4 conditioning appeared to achieve clinical outcomes similar to BuCy2 and may be considered as a possible alternative for patients at high risk of NRM.
Authors
- Sabrine Mekni (ORCID: https://orcid.org/0009-0006-3251-6038)
- Lamia Torjemane
- Dorra Belloumi
- Saloua Ladeb (ORCID: https://orcid.org/0000-0001-8197-6504)
- Ben Othman T
- Rihab Ouerghi
- Rimel Yousr Kanoun
- Ilhem Turki (ORCID: https://orcid.org/0000-0003-2644-3128)
- Ben Abdeljelil N
- Ben Yaiche
Institutions
- National Marrow Donor Program (US)
- National Sanitation Utility (TN)
Publication Details
- Journal
- Future Oncology
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1080/14796694.2025.2507563
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00